|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.94 EUR | -1.49% |
|
-2.39% | +40.61% |
| 07-24 | Viatris Wins European Medicines Agency's Positive Opinion for Ruxolitinib Viatris | MT |
| 07-24 | Merck licenses experimental HIV pill to generic makers in 129 countries | RE |
| Market Cap | 20.08B 17.63B 16.4B 15.05B 28.27B 1,933B 28.71B 195B 76.08B 951B 75.37B 73.74B 3,287B | P/E 2026 * |
75.8x | P/E 2027 * | 32.1x |
|---|---|---|---|---|---|
| Enterprise Value | 32.26B 28.34B 26.35B 24.18B 45.44B 3,107B 46.14B 313B 122B 1,528B 121B 119B 5,281B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 2.08x |
| Free-Float |
92.23% | Yield 2026 * |
2.95% | Yield 2027 * | 3.03% |
Last Transcript: Viatris Inc.
| 1 day | -1.49% | ||
| 1 week | -2.39% | ||
| Current month | +6.99% | ||
| 1 month | +6.35% | ||
| 3 months | +19.79% | ||
| 6 months | +32.68% | ||
| Current year | +40.61% |
| 1 week | 14.94 |  | 15.3 |
| 1 month | 13.96 | | 15.31 |
| Current year | 10.52 | | 15.31 |
| 1 year | 7.51 | | 15.31 |
| 3 years | 6.45 | | 15.31 |
| 5 years | 6.45 | | 15.31 |
| 10 years | 6.45 | | 15.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 63 | 2023-03-31 |
Paul Campbell
DFI | Director of Finance/CFO | 59 | 2026-05-07 |
Philippe Martin
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Wyllie Cornwell
BRD | Director/Board Member | 78 | 2020-11-15 |
James Kilts
BRD | Director/Board Member | 78 | 2020-11-15 |
JoEllen Dillon
BRD | Director/Board Member | 62 | 2020-11-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.49% | -2.39% | - | - | 20.08B | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,067B | |
| +1.59% | +4.09% | +55.34% | +53.96% | 635B | |
| +0.95% | +1.91% | +35.91% | +81.14% | 458B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 347B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 295B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 216B | |
| +1.22% | +2.66% | +21.87% | +59.73% | 203B | |
| -1.18% | -3.70% | +14.23% | +66.51% | 161B | |
| Average | +0.18% | +1.33% | +25.93% | +51.91% | 404.78B | |
| Weighted average by Cap. | +0.53% | +1.95% | +35.81% | +77.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.79B 12.99B 12.08B 11.09B 20.83B 1,425B 21.15B 143B 56.06B 700B 55.53B 54.33B 2,421B | 15.05B 13.22B 12.29B 11.28B 21.2B 1,449B 21.52B 146B 57.04B 713B 56.5B 55.29B 2,464B |
| Net income | 3.05M 2.68M 2.49M 2.29M 4.3M 294M 4.36M 29.6M 11.56M 144M 11.46M 11.21M 500M | 339M 298M 277M 254M 477M 32.62B 484M 3.29B 1.28B 16.04B 1.27B 1.24B 55.45B |
| Net Debt | 12.19B 10.7B 9.95B 9.13B 17.16B 1,174B 17.43B 118B 46.18B 577B 45.75B 44.76B 1,995B | 11.18B 9.82B 9.14B 8.38B 15.75B 1,077B 15.99B 108B 42.38B 530B 41.99B 41.08B 1,831B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | €15.19 | +1.70% | 0 |
| 26-07-23 | €14.94 | -1.49% | 0 |
| 26-07-22 | €15.17 | +0.07% | 150 |
| 26-07-21 | €15.16 | +0.44% | 864 |
| 26-07-20 | €15.09 | -1.41% | 168 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VTRS Stock
- 1VTRS Stock
Select your edition
All financial news and data tailored to specific country editions
